The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Phase transformation considerations during process development and manufacture of solid oral dosage forms
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Formation of Glasses from Liquids and Biopolymers
Angell, C. A. (1995) · Science · doi:10.1126/science.267.5206.1924 · Cited by 4,799
The Nature of the Glassy State and the Behavior of Liquids at Low Temperatures.
Kauzmann, W. (1948) · Chemical Reviews · doi:10.1021/cr60135a002 · Cited by 2,834
Characteristics and Significance of the Amorphous State in Pharmaceutical Systems
Hancock, B. C., & Zografi, G. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601896 · Cited by 1,922
The Physics of Amorphous Solids
Zallen, R., & Penchina, C. M. (1986) · American Journal of Physics · doi:10.1119/1.14422 · Cited by 1,841
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Hancock, B. C., & Parks, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007516718048 · Cited by 1,358
Remington's pharmaceutical sciences
(1976) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600650641 · Cited by 1,136
Polymorphism in Pharmaceutical Solids
(2018) · CRC Press eBooks · doi:10.3109/9781420073225 · Cited by 1,099
Solid state chemistry of drugs
Byrn, S. R. (1982) · Medical Entomology and Zoology · Cited by 1,086
Pharmaceutical Applications of Polymorphism
Haleblian, J., & McCrone, W. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580802 · Cited by 855
Polymorphism and Polytypism in Crystals
Verma, A. R., Krishna, P., & Otte, H. M. (1967) · Physics Today · doi:10.1063/1.3034193 · Cited by 692
Pharmaceutical Dosage Forms: taBlets
(2016) · Pharmaceutical Dosage Forms - Tablets · doi:10.1201/b15115-46 · Cited by 620
Drug-delivery Products and the Zydis Fast-dissolving Dosage Form
Seager, H. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06876.x · Cited by 581
Ahlneck, C., & Zografi, G. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90221-o · Cited by 554
Analysis of organic polymorphs. A review
Threlfall, T. L. (1995) · The Analyst · doi:10.1039/an9952002435 · Cited by 552
The kinetics of solvent-mediated phase transformations
Cardew, P. T., & Davey, R. J. (1985) · Proceedings of the Royal Society of London. A. Mathematical and Physical Sciences · doi:10.1098/rspa.1985.0043 · Cited by 357
Morris, K. R., Griesser, U. J., Eckhardt, C. J., & Stowell, J. G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00100-4 · Cited by 345
Zhou, D., Zhang, G. G. Z., Law, D., Grant, D. J. W., & Schmitt, E. A. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10169 · Cited by 336
Self-citationStrategies for particle design using supercritical fluid technologies
York, P. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00209-6 · Cited by 232
Ward, G. H., & Schultz, R. K. (1995) · Pharmaceutical Research · doi:10.1023/a:1016232230638 · Cited by 230
Polymorphism in Anhydrous Theophylline—Implications on the Dissolution Rate of Theophylline Tablets
Phadnis, N. V., & Suryanarayanan, R. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9701418 · Cited by 191
Andronis, V., & Zografi, G. (1998) · Pharmaceutical Research · doi:10.1023/a:1011960112116 · Cited by 170
The Bioinequivalence of Carbamazepine Tablets with a History of Clinical Failures
Meyer, M. C., Straughn, A. B., Jarvi, E. J., Wood, G. C., Pelsor, F. R., & Shah, V. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015872626887 · Cited by 157
Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance
Hancock, B. C., Carlson, G. T., Ladipo, D. D., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00133-3 · Cited by 110
The effect of surfactants on the crystallization and polymorphic transformation of glutamic acid
Garti, N., & Zour, H. (1997) · Journal of Crystal Growth · doi:10.1016/s0022-0248(96)00771-3 · Cited by 99
Crystallization Kinetics of Amorphous Nifedipine Studied by Model-Fitting and Model-Free Approaches
Zhou, D., Schmitt, E. A., Zhang, G. G., Law, D., Vyazovkin, S., Wight, C. A., & Grant, D. J. W. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10425 · Cited by 99
Self-citationVitrification of trehalose by water loss from its crystalline dihydrate
Ding, S., Fan, J., Green, J. L., Lu, Q. H., Sánchez, E. M., & Angell, C. A. (1996) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/bf01992835 · Cited by 85
Glass Fragility and the Stability of Pharmaceutical Preparations—Excipient Selection
Hatley, R. H. M. (1997) · Pharmaceutical Development and Technology · doi:10.3109/10837459709031445 · Cited by 55
Carstensen, J. T., & Attarchi, F. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770407 · Cited by 32
Effect of Physicochemical and Formulation Variables on the In Vivo Absorption of ABT-761
Qiu, Y., Fort, J. J., Trivedi, J. S., Gerhardt, A., Mayer, P. T., Briskin, J., & Schilling, R. J. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120002844 · Cited by 4
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Baird, J. A., Van Eerdenbrugh, B., & Taylor, L. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22197 · Cited by 697
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs
Censi, R., & Di Martino, P. (2015) · Molecules · doi:10.3390/molecules201018759 · Cited by 512
Assessment of Recent Process Analytical Technology (PAT) Trends: A Multiauthor Review
Simon, L. L., Pataki, H., Marosi, G., Meemken, F., Hungerbühler, K., Baiker, A., Tummala, S., Glennon, B., Kuentz, M., Steele, G., et al. (2015) · Organic Process Research & Development · doi:10.1021/op500261y · Cited by 439
Metadata
- Authors
- Zhang, G.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2004-02-23
- Volume
- 56
- Issue
- 3
- Pages
- 371-390
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2015769892
- Cited by
- 462
- References
- 29
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.